Chun-ping Chang
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Population-specific polygenic risk scores for people of Han Chinese ancestry.
Journal: Nature
Published: October 14, 2024
Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus.
Journal: Molecular cancer therapeutics
Published: September 09, 2023
Identifying the nexus among environmental performance, digital finance, and green innovation: New evidence from prefecture-level cities in China.
Journal: Journal of environmental management
Published: November 20, 2022
What are the pandemic's shocks on carbon emission trading? The different management applications.
Journal: Air quality, atmosphere, & health
Published: November 11, 2022
Environmental governance and innovation: an overview.
Journal: Environmental science and pollution research international
Published: January 04, 2022
The transaction behavior of cryptocurrency and electricity consumption.
Journal: Financial innovation
Published: November 21, 2021
Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins.
Journal: Journal of medicinal chemistry
Published: May 19, 2021
Correction to "Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir".
Journal: ACS pharmacology & translational science
Published: April 13, 2021
Economic policy uncertainty and energy production in China.
Journal: Environmental science and pollution research international
Published: April 06, 2021
Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.
Journal: ACS pharmacology & translational science
Published: January 15, 2021
What is the relationship between government response and COVID-19 pandemics? Global evidence of 118 countries.
Journal: Structural change and economic dynamics
Published: January 14, 2021
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.
Journal: Frontiers in pharmacology
Published: September 14, 2020
Last Updated: 09/26/2026